Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning
Japanese Journal of Transplantation and Cellular Therapy · 2022
DOI: 10.7889/tct-21-001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Transplantation and Cellular Therapy, 2022. Verfasst von Takeshi Sugio und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Cord blood is an alternative donor source for patients without HLA-matched donors. Calcineurin inhibitors (CNIs) alone, as prophylaxis for graft-versus-host disease (GVHD) in cord blood transplantation (CBT) patients, reportedly increase the incidence of severe pre-engraftment immune reaction (PIR), leading to transplant-related mortality (TRM) with primary engraft failure and multiple organ dysfunctions. Therefore, additional immunosuppressive agents are needed. Reportedly, short-term methotrexate (sMTX) plus CNIs improved outcomes in patients receiving CBT with full-intensity conditioning (FIC) regimens; however, safety and efficacy of sMTX plus cyclosporine have not been assessed in patients receiving CBT with reduced-intensity conditioning (RIC) regimens.
Methods
We retrospectively analyzed 43 patients who received single-unit CBT and were treated with sMTX plus cyclosporine (RIC group, 15; FIC group, 28).
Results
Neutrophil engraftment rate was significantly lower in RIC group (53.3%) than in FIC group (78.6%, P=0.04). Cumulative incidence of TRM tended to be higher in the RIC group than in the FIC group (P=0.12); the leading cause of death in the RIC group was bacterial infections. Conclusions: sMTX plus cyclosporine does not seem feasible for treating patients receiving single-unit CBT following RIC. MTX dose optimization or alternative immunosuppressive agent application should be considered in such patients.
Zitieren
APA
Sugio, T., Kato, K., Yoshida, S., Saito, N., Kawano, I., Henzan, H., Miyamoto, T., Akashi, K., & Eto, T. (2022). Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning. Japanese Journal of Transplantation and Cellular Therapy. https://doi.org/10.7889/tct-21-001
Vancouver
Sugio T, Kato K, Yoshida S, Saito N, Kawano I, Henzan H, et al. Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning. Japanese Journal of Transplantation and Cellular Therapy. 2022. doi:10.7889/tct-21-001
BibTeX
@article{Sugio2022,
author = {Sugio, Takeshi and Kato, Koji and Yoshida, Shuro and Saito, Noriyuki and Kawano, Ichiro and Henzan, Hideho and Miyamoto, Toshihiro and Akashi, Koichi and Eto, Tetsuya},
title = {Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning},
journal = {Japanese Journal of Transplantation and Cellular Therapy},
year = {2022},
doi = {10.7889/tct-21-001}
}
EUVIMED